ACS Clinical Research Program rss

Alliance for Clinical Trials in Oncology

Limited resection as a cure for early lung cancer: Time to challenge the gold standard?(Comments Off)

May 1, 2015

A clinical trial is exploring whether limited resection should replace lobectomy as the gold standard for treatment of early-stage lung cancer.

clinical-res-fig1

Progress in the PROSPECT trial: Precision treatment for rectal cancer?

The PROSPECT trial for individualized treatment is discussed in this month’s column as is the surgeon’s role in ensuring the success of this trial.

Figures 1A, 1B, 1C, 1D

Colorectal cancer metastatic to the liver: Making the unresectable resectable

Advances in the treatment of metastatic colorectal cancer have led to greatly improved survival rates, especially for patients with liver-only disease. These new approaches have increased the role of surgeons in the management of these patients.

alliance logo CMYK

QOL concerns in surgical patients: Assessment and intervention

Deficits in perioperative quality of life and rehabilitation programs are described in this article, as are practical interventions for integrating the patient’s perspective into care management.

Treating metastatic prostate cancer now and in the future

The past decade has seen a paradigm shift in the treatment of men with advanced prostate cancer, according to the authors of this month column, a result of improved understanding of disease biology, investment in basic research and identification of rational therapeutic targets, collaboration with industry, and design and completion of well-designed clinical trials.


More in this category

« Older Posts   

Contact

Bulletin of the American College of Surgeons
633 N. Saint Clair St.
Chicago, IL 60611